Severity of mastalgia in relation to milk duct dilatation

Obstetrics and Gynecology

Volumn 101, Issue 1, 2003, Pages 54-60

  Peters, Friedolf ^a,b   Diemer, Petra ^a,b   Mecks, Olaf ^a,b   Behnken, Lütje J ^a,b  

^a St Hildegardis Krankenhaus   (Germany)

^b Bioscientia Center for Human Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BREAST; BREAST DUCT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GENITAL SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; PAIN ASSESSMENT; PREMENOPAUSE; PRIORITY JOURNAL; SCREENING; STATISTICAL ANALYSIS; SYMPTOM;

ADOLESCENT; ADULT; BREAST; BREAST DISEASES; DILATATION, PATHOLOGIC; FEMALE; HUMANS; MIDDLE AGED; PAIN; ULTRASONOGRAPHY, MAMMARY;

EID: 0037222578     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02386-4     Document Type: Article

References (30)

1. Venta L.A. Image-guided biopsy of nonpalpable breast lesions. Harriss J.R., Lippman M.E., Morrow M., Osborne C.K. Diseases of the breast. 2nd ed:2000;149-164 Lippincott, Williams & Wilkins, Philadelphia.
2. King T.A., Carter K.M., Bolton J.S., Fuhrmann G.M. A simple approach to nipple discharge. Arch Surg. 69:2000;960-965.
3. Peters F, Kielich A, Pahnke V. Coincidence of non-puerperal mastitis and breast cancer. Eur J Obstet Gynecol Reprod Biol 2002. In press.
4. Preece P.E., Baum M., Mansel R.E., Webster D.J., Fortt R.W., Gravelle I.C.H., et al. Importance of mastalgia in operable breast cancer. BMJ. 248:1982;1299-1300.
5. Watt-Boolsen S., Emus H., Junge J. Fibrocystic disease and mastalgia. Dan Med Bull. 29:1982;252-254.
6. Jorgensen J., Watt-Boolsen S. Cyclical mastalgia and breast pathology. Acta Chir Scand. 151:1985;319-321.
7. Preece P.E., Mansel R.E., Bolten P.M., Hughes L.E., Baum M., Gravelle I.H. Clinical syndromes of mastalgia. Lancet. 2:1976;670-673.
8. Peters F., Schuth W., Scheurich B., Breckwoldt M. Serum prolactin levels in patients with fibrocystic breast disease. Obstet Gynecol. 64:1984;381-385.
9. Goodwin P.J., Miller A., Del Giudice E., Singer W., Conelly P., Ritchie J.W.K. Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclical mastopathy. Am J Obstet Gynecol. 179:1998;430-437.
10. Peters F., Pickardt C.R., Breckwold M. Thyroid hormones in benign breast disease Normalization of exaggerated prolactin responsiveness to thyrotropin-releasing hormone . Cancer. 65:1985;102-105.
11. Peters F. Multicentre study of gestrinone in cyclical breast pain. Lancet. 339:1996;205-208.
12. Pye J.K., Mansel R.E., Hughes L.E. Clinical experience of drug treatment for mastalgia. Lancet. 2:1985;373-376.
13. Boyd N.F., McGuire V., Shannon P., Cousins M., Kriukov V., Mahoney L., et al. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet. 2:1988;128-132.
14. Wellings S.R., Wolfe J.N. Correlative studies of the histological and radiographic appearance of the breast parenchyma. Radiology. 129:1978;299-306.
15. Moskowitz M., Gartside P., McLaughlin C. Mammographic patterns as markers for high risk benign breast disease and incident cancer. Radiology. 134:1980;293-295.
16. Ayers J., Gidwani G. The "luteal breast" and hormonal and sonographic investigation of benign breast in patients with cyclical mastalgia. Fertil Steril. 408:1983;779-784.
17. Tawaf-Mutamen H., Ader D.N., Browne M.W., Shriver C.D. Clinical evaluation of mastalgia. Arch Surg. 133:1998;211-213.
18. Harper P., Kelly-Fry E. Ultrasound visualization of the breast in symptomatic patients. Radiology. 137:1980;465-469.
19. Griffith C.D.M., Dowle C.S., Hinton C.P., Blamey R.W. The breast pain clinic A rational approach to classification and treatment of breast pain . Postgrad Med J. 63:1987;547-549.
20. Halloran B.P., DeLuca H.F. Calcium transport in small intestine during pregnancy and lactation. Am J Physiol. 239:1992;64-68.
21. Stier C.T., Cowden E.A., Friesen H.G. Prolactin and the rat kidney A clearance and micropuncture study . Endocrinology. 115:1984;362-367.
22. Tyson J.E. The evolutionary role of prolactin in mammalian osmoregulation Effects on fetoplacental hydromineral transport . Semin Perinatol. 6:1982;216-228.
23. Döring G.K. Über Veränderungen des Brustvolumens im Cyclus. Arch Gynecol. 184:1953;51-58.
24. Rose D.P., Berke B., Cohen L.A., Lahti H. A comparison of serum and breast duct fluid-immunoassayable prolaction and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease. Cancer. 60:1987;2761-2765.
25. Kumar S., Mansel R.E., Hughes L.E., Woodhead J.S., Edwards C.A., Scanlon M.F., et al. Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer. 153:1984;1311-1315.
26. Vorherr H. The breast: Morphology, physiology and lactation. 1974;Academic Press, New York.
27. Tedeschi L., Ahari S., Byrne J. Involutional mammary duct ectasia and periductal mastitis. Am J Surg. 106:1963;517-521.
28. Haagensen C.D. Mammary-duct ectasia A disease which may simulate carcinoma . Cancer. 4:1951;749-761.
29. Bonser G.M., Dossett J.A., Jull J.W. Human and experimental breast cancer. 1961;237-249 Pitman Medical, London.
30. Dixon J.M., Ravi Sekar O., Chetty U., Anderson T.J. Periductal mastitis and duct ectasia Different conditions with different aetiologies . Br J Surg. 83:1996;820.